187 related articles for article (PubMed ID: 25561420)
1. MiR-17-5p up-regulates YES1 to modulate the cell cycle progression and apoptosis in ovarian cancer cell lines.
Li L; He L; Zhao JL; Xiao J; Liu M; Li X; Tang H
J Cell Biochem; 2015 Jun; 116(6):1050-9. PubMed ID: 25561420
[TBL] [Abstract][Full Text] [Related]
2. miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1.
Fang Z; Yin S; Sun R; Zhang S; Fu M; Wu Y; Zhang T; Khaliq J; Li Y
Mol Cancer; 2017 Aug; 16(1):139. PubMed ID: 28818100
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.
Tan W; Lim SG; Tan TM
World J Gastroenterol; 2015 Dec; 21(46):13030-41. PubMed ID: 26676187
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancer.
Liu L; Yang J; Zhu X; Li D; Lv Z; Zhang X
FEBS J; 2016 Jun; 283(12):2326-39. PubMed ID: 27093644
[TBL] [Abstract][Full Text] [Related]
5. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
Li X; Chen W; Jin Y; Xue R; Su J; Mu Z; Li J; Jiang S
Biochem Pharmacol; 2019 Mar; 161():98-112. PubMed ID: 30639456
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-497-5p Functions as a Modulator of Apoptosis by Regulating Metadherin in Ovarian Cancer.
Liu C; Bordeaux A; Hettich S; Han S
Cell Transplant; 2020; 29():963689719897061. PubMed ID: 32046519
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis.
Hao SD; Ma JX; Liu Y; Liu PJ; Qin Y
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):619-632. PubMed ID: 32016963
[TBL] [Abstract][Full Text] [Related]
8. LncRNA12097.1 contributes to endometrial cell growth by enhancing YES1 activating β-catenin via sponging miR-145-5p.
Li X; Li K; Deng K; Liu Z; Huang X; Guo J; Yang F; Wang F
Int J Biol Macromol; 2024 Jan; 256(Pt 2):128477. PubMed ID: 38035963
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-140 attenuates myocardial ischemia-reperfusion injury through suppressing mitochondria-mediated apoptosis by targeting YES1.
Yang S; Li H; Chen L
J Cell Biochem; 2019 Mar; 120(3):3813-3821. PubMed ID: 30259997
[TBL] [Abstract][Full Text] [Related]
10. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
Zhou S; Xu A; Song T; Gao F; Sun H; Kong X
Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927
[No Abstract] [Full Text] [Related]
11. Effect of miR-140-5p on the regulation of proliferation and apoptosis in NSCLC and its underlying mechanism.
Zhou W; Wang X; Yin D; Xue L; Ma Z; Wang Z; Zhang Q; Zhao Z; Wang H; Sun Y; Yang Y
Exp Ther Med; 2019 Aug; 18(2):1350-1356. PubMed ID: 31363375
[TBL] [Abstract][Full Text] [Related]
12. Prostatitis No.1 traditional chinese medicine significantly exhibited anti-inflammation role on prostatitis through miR-205-5p/YES1.
Liu J; Fan Y; Song R; Tian Z; Yan B; Ma Y; Zeng Q
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(15):270-276. PubMed ID: 38279415
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-140 inhibit prostate cancer cell invasion and migration by targeting YES proto-oncogene 1.
Zhao S; Jie C; Xu P; Diao Y
J Cell Biochem; 2020 Jan; 121(1):482-488. PubMed ID: 31310382
[TBL] [Abstract][Full Text] [Related]
14. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
15. LncSNHG14 promotes ovarian cancer by targeting microRNA-125a-5p.
Zhao YL; Huang YM
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3235-3242. PubMed ID: 31081075
[TBL] [Abstract][Full Text] [Related]
16. MiR-199a suppresses prostate cancer paclitaxel resistance by targeting YES1.
Chen L; Cao H; Feng Y
World J Urol; 2018 Mar; 36(3):357-365. PubMed ID: 29204706
[TBL] [Abstract][Full Text] [Related]
17. Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
Takeda T; Yamamoto H; Kanzaki H; Suzawa K; Yoshioka T; Tomida S; Cui X; Murali R; Namba K; Sato H; Torigoe H; Watanabe M; Shien K; Soh J; Asano H; Tsukuda K; Kitamura Y; Miyoshi S; Sendo T; Toyooka S
PLoS One; 2017; 12(2):e0171356. PubMed ID: 28158234
[TBL] [Abstract][Full Text] [Related]
18. MiR-133 Targets YES1 and Inhibits the Growth of Triple-Negative Breast Cancer Cells.
Zhang G; Wang J; Zheng R; Song B; Huang L; Liu Y; Hao Y; Bai X
Technol Cancer Res Treat; 2020; 19():1533033820927011. PubMed ID: 32462982
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LINC00460 promotes proliferation and inhibits apoptosis of cervical cancer cells by targeting microRNA-503-5p.
Lin L; Xin B; Jiang T; Wang XL; Yang H; Shi TM
Mol Cell Biochem; 2020 Dec; 475(1-2):1-13. PubMed ID: 32740791
[TBL] [Abstract][Full Text] [Related]
20. Linc01133 contributes to gastric cancer growth by enhancing YES1-dependent YAP1 nuclear translocation via sponging miR-145-5p.
Sun Y; Tian Y; He J; Tian Y; Zhang G; Zhao R; Zhu WJ; Gao P
Cell Death Dis; 2022 Jan; 13(1):51. PubMed ID: 35017464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
